The nuclear isoform of the LIM domain protein Trip6 integrates activating and repressing signals at the promoter-bound glucocorticoid receptor

Molecular and Cellular Endocrinology

Volumn 320, Issue 1-2, 2010, Pages 58-66

  Diefenbacher, Markus E ^a,b   Litfin, Margarethe ^a   Herrlich, Peter ^b   Kassel, Olivier ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

AP 1; Co activator; Glucocorticoid receptor; NF B; Transrepression; Trip6

Indexed keywords

CELL NUCLEUS RECEPTOR; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; LIM PROTEIN; PROTEIN; PROTEIN TRIP6; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL NUCLEUS; HUMANS; MICE; MUTATION; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, GLUCOCORTICOID; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS;

EID: 77949569973     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.010     Document Type: Article

References (49)

1. Aoyagi S., Archer T.K. Dynamics of coactivator recruitment and chromatin modifications during nuclear receptor mediated transcription. Mol. Cell. Endocrinol. 2008, 280:1-5.
2. Bai C.Y., Ohsugi M., Abe Y., Yamamoto T. ZRP-1 controls Rho GTPase-mediated actin reorganization by localizing at cell-matrix and cell-cell adhesions. J. Cell Sci. 2007, 120:2828-2837.
3. Bosisio D., Marazzi I., Agresti A., Shimizu N., Bianchi M.E., Natoli G. A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. EMBO J. 2006, 25:798-810.
4. Burkhart B.A., Hebbar P.B., Trotter K.W., Archer T.K. Chromatin-dependent E1A activity modulates NF-kappaB RelA-mediated repression of glucocorticoid receptor-dependent transcription. J. Biol. Chem. 2005, 280:6349-6358.
5. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., Okret S., Gustafsson J.A., Van der Saag P.T. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 1995, 9:401-412.
6. Chinenov Y., Kerppola T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001, 20:2438-2452.
7. D'Adamio F., Zollo O., Moraca R., Ayroldi E., Bruscoli S., Bartoli A., Cannarile L., Migliorati G., Riccardi C. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 1997, 7:803-812.
8. Dawid I.B., Breen J.J., Toyama R. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet. 1998, 14:156-162.
9. Diefenbacher M., Sekula S., Heilbock C., Maier J.V., Litfin M., van Dam H., Castellazzi M., Herrlich P., Kassel O. Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1. Mol. Endocrinol. 2008, 22:1767-1780.
10. Eferl R., Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 2003, 3:859-868.
11. Fujimoto N., Yeh S., Kang H.Y., Inui S., Chang H.C., Mizokami A., Chang C. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J. Biol. Chem. 1999, 274:8316-8321.
12. Ghogomu S.M., van Venrooy S., Ritthaler M., Wedlich D., Gradl D. HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription. J. Biol. Chem. 2006, 281:1755-1764.
13. Guerrero-Santoro J., Yang L., Stallcup M.R., DeFranco D.B. Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation. J. Cell. Biochem. 2004, 92:810-819.
14. Guryanova O.A., Sablina A.A., Chumakov P.M., Frolova E.I. Downregulation of TRIP6 gene expression induces actin cytoskeleton rearrangements in human carcinoma cell lines. Mol. Biol. 2005, 39:792-795.
15. Heck S., Bender K., Kullmann M., Göttlicher M., Herrlich P., Cato A.C. I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J. 1997, 16:4698-4707.
16. Heitzer M.D., DeFranco D.B. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. Mol. Endocrinol. 2006, 20:56-64.
17. Hess J., Angel P., Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 2004, 117:5965-5973.
18. Hu C.D., Chinenov Y., Kerppola T.K. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 2002, 9:789-798.
19. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990, 62:1189-1204.
20. Kasai M., Guerrero-Santoro J., Friedman R., Leman E.S., Getzenberg R.H., DeFranco D.B. The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. Cancer Res. 2003, 63:4927-4935.
21. Kassel O., Herrlich P. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol. Cell. Endocrinol. 2007, 275:13-29.
22. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 2001, 20:7108-7116.
23. Kassel O., Schneider S., Heilbock C., Litfin M., Göttlicher M., Herrlich P. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-κB-regulated promoters. Genes Dev. 2004, 18:2518-2528.
24. Lai Y.J., Chen C.S., Lin W.C., Lin F.T. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration. Mol. Cell. Biol. 2005, 25:5859-5868.
25. Lucibello F.C., Slater E.P., Jooss K.U., Beato M., Muller R. Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J. 1990, 9:2827-2834.
26. Maroder M., Farina A.R., Vacca A., Felli M.P., Meco D., Screpanti I., Frati L., Gulino A. Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription. Mol. Endocrinol. 1993, 7:570-584.
27. McKay L.I., Cidlowski J.A. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol. Endocrinol. 1998, 12:45-56.
28. Métivier R., Reid G., Gannon F. Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO Rep. 2006, 7:161-167.
29. Pascussi J.-M., Gerbal-Chaloin S., Duret C.d., Daujat-Chavanieu M., Vilarem M.-J., Maurel P. The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu. Rev. Pharmacol. Toxicol. 2008, 48:1-32.
30. Rahman M.M., Miyamoto H., Lardy H., Chang C. Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5124-5129.
31. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:752-756.
32. Scheinman R.I., Gualberto A., Jewell C.M., Cidlowski J.A., Baldwin A.S. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 1995, 15:943-953.
33. Schüle R., Rangarajan P., Kliewer S., Ransone L.J., Bolado J., Yang N., Verma I.M., Evans R.M. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990, 62:1217-1226.
34. Shemshedini L., Knauthe R., Sassone-Corsi P., Pornon A., Gronemeyer H. Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J. 1991, 10:3839-3849.
35. Shimizu N., Hashizume T., Shingaki K., Kawamoto J.K. Amplification of plasmids containing a mammalian replication initiation region is mediated by controllable conflict between replication and transcription. Cancer Res. 2003, 63:5281-5290.
36. Shimizu N., Miura Y., Sakamoto Y., Tsutsui K. Plasmids with a mammalian replication origin and a matrix attachment region initiate the event similar to gene amplification. Cancer Res. 2001, 61:6987-6990.
37. Sugaya K., Vigneron M., Cook P.R. Mammalian cell lines expressing functional RNA polymerase II tagged with the green fluorescent protein. J. Cell Sci. 2000, 113(Pt 15):2679-2683.
38. Touray M., Ryan F., Jaggi R., Martin F. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun. Oncogene 1991, 6:1227-1234.
39. Vallabhapurapu S., Karin M. Regulation and function of NF-kB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
40. Waltner-Law M., Daniels M.C., Sutherland C., Granner D.K. NF-kappa B inhibits glucocorticoid and cAMP-mediated expression of the phosphoenolpyruvate carboxykinase gene. J. Biol. Chem. 2000, 275:31847-31856.
41. Wang H., Song K., Sponseller T.L., Danielpour D. Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling. J. Biol. Chem. 2005, 280:5154-5162.
42. Wang L., Zhang X., Farrar W.L., Yang X. Transcriptional crosstalk between nuclear receptors and cytokine signal transduction pathways in immunity. Cell. Mol. Immunol. 2004, 1:416-424.
43. Wang Y., Gilmore T.D. Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear. Biochim. Biophys. Acta 2003, 1593:115-120.
44. Weiss C., Faust D., Durk H., Kolluri S.K., Pelzer A., Schneider S., Dietrich C., Oesch F., Göttlicher M. TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Oncogene 2005, 24:4975-4983.
45. Wissink S., van Heerde E.C., Schmitz M.L., Kalkhoven E., van der Burg B., Baeuerle P.A., van der Saag P.T. Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J. Biol. Chem. 1997, 272:22278-22284.
46. Xu J., Lai Y.J., Lin W.C., Lin F.T. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor. J. Biol. Chem. 2004, 279:10459-10468.
47. Yang L., Guerrero J., Hong H., DeFranco D.B., Stallcup M.R. Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol. Biol. Cell 2000, 11:2007-2018.
48. Yang-Yen H.F., Chambard J.C., Sun Y.L., Smeal T., Schmidt T.J., Drouin J., Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990, 62:1205-1215.
49. Zheng Q., Zhao Y. The diverse biofunctions of LIM domain proteins: determined by subcellular localization and protein-protein interaction. Biol. Cell 2007, 099:489-502.